CUP-mRCC Treated With VEGF-Targeted Therapy Is Valid, Feasible, and Safe
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature
Clin Genitourin Cancer 2019 Feb 01;17(1)e32-e37, A Overby, L Duval, M Ladekarl, BE Laursen, F DonskovFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.